Global Brain Tumor Diagnosis And Therapeutics (MRI, CT Scan, Tissue Sampling, PET-CT Scan, Cerebral Arteriogram, Lumbar Puncture, Molecular Testing, And EEG) Market 2014-2017 & 2025 - Research and Markets

News provided by

Research and Markets

19 Apr, 2017, 13:45 GMT

DUBLIN, Apr. 19, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Brain Tumor Diagnosis And Therapeutics Market Analysis By Type (MRI, CT Scan, Tissue Sampling, PET-CT Scan, Cerebral Arteriogram, Lumbar Puncture, Molecular Testing, And EEG), By Region, And Segment Forecasts, 2014 - 2025" report to their offering.

The global brain tumor diagnosis and therapeutics market is expected to reach USD 773.1 million by 2025

The market is expected to pose lucrative growth over the forecast period, owing to increasing incidence of various brain cancers, particularly glioblastoma, coupled with rising geriatric population.

Increasing Public-Private Partnerships (PPPs) in the health sector, which are modernizing diagnostic imaging and radiology services, are supporting the expansion of this industry. Emerging technologies like Sodium Magnetic Resonance Imaging(23Na MRI), Positron Emission Tomography (PET), and Chemical Exchange Saturation Transfer (CEST) are used to detect the response of brain tumors in multicenter clinical trial settings. In addition, these technologies are helpful in quantitatively imaging tumor response to therapies, thereby promoting their use during treatment.

These technologies have the potential to extend MRI beyond anatomical imaging by providing information on physiology and cellular metabolism, thereby increasing the efficiency of diagnosis. Hence, the market is expected to witness productive growth over the forecast period.

Moreover, ongoing research in molecular diagnostics to understand cell biology at cellular level of malignancy and identification of gene mutations associated with malignancy is anticipated to significantly contribute toward the growth of the industry.

On the other hand, high cost of diagnosing brain tumors, which ranges from USD 450 to 12,200, is likely to hinder the growth of the global brain tumor diagnosis market.

Further Key Findings From the Study Suggest:

  • CT scan segment held a lucrative revenue share in 2015 and is also likely to grow at a significant rate during the forecast period
  • Chemotherapy is anticipated to witness the fastest growth over the forecast period owing to presence of a large research pipeline by the industry players.
  • North America is expected to dominate the brain tumor diagnosis and therapeutics market, owing to developed healthcare infrastructure coupled with rising awareness regarding advanced technologies amongst the population in this region. In addition, increasing consumer disposable income supported by healthcare insurance and reimbursement policies in the U.S. is expected to spur growth.
  • Some of the key players for the brain tumor diagnosis and therapeutics market are GE Healthcare; Hitachi, Ltd.; Philips Healthcare; Siemens Healthineers; Toshiba Corporation; Fujifilm Corporation; Shimadzu Corporation; Carestream Health; Merck & Co.; Astra Zeneca; Bristol Myer Squibb; Novartis; and Roche Diagnostics.

Key Topics Covered:

1. Methodology and Scope

2. Executive Summary

3. Brain Tumor Diagnosis and Therapeutics Market Variables, Trends & Scope
3.1. Market Segmentation & Scope
3.2. Market Driver Analysis
3.3. Penetration & Growth Prospect Mapping
3.4. SWOT Analysis, by Factor
3.4.1. Political
3.4.2. Economic
3.4.3. Technological
3.5. Industry Analysis - Porter's

4. Brain Tumor Diagnosis and Therapeutics Market: Type Estimates & Trend Analysis
4.1. Type Movement Analysis & Market Share, 2015 & 2025
4.2. Market Size Estimates & Forecasts and Trend Analyses, 2014 to 2025 for the following type:
4.2.1. MRI
4.2.2. CT scan
4.2.3. Tissue sampling
4.2.4. PET-CT scan
4.2.5. Cerebral arteriogram
4.2.6. Lumbar puncture
4.2.7. Molecular testing
4.2.8. EEG

5. Brain Tumor Diagnosis and Therapeutics Market: Therapeutics Estimates & Trend Analysis
5.1. Therapeutics Movement Analysis & Market Share, 2015 & 2025
5.2. Market Size Estimates & Forecasts and Trend Analyses, 2014 to 2025 for the following therapeutics:
5.2.1. Surgery
5.2.2. Radiation therapy
5.2.3. Chemotherapy
5.2.4. Immunotherapy
5.2.5. Targeted therapy

6. Brain Tumor Diagnosis and Therapeutics Market: Regional Estimates & Trend Analysis

7. Competitive Landscape

  • GE Healthcare
  • Hitachi, Ltd.
  • Philips Healthcare
  • Siemens Healthineers
  • Toshiba Corporation
  • Fujifilm Corporation
  • Shimadzu Corporation
  • Carestream Health

For more information about this report visit http://www.researchandmarkets.com/research/st35q7/brain_tumor

About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Related Links

http://www.researchandmarkets.com